[Efficacy of atovaquone in resistant toxoplasmosis in AIDS].
Lafeuillade
A
A
Pellegrino
P
P
Poggi
C
C
Profizi
N
N
Quilichini
R
R
Chouette
I
I
Navarreté
M S
MS
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D053626:Atovaquone; D004352:Drug Resistance, Microbial; D006801:Humans; D009285:Naphthoquinones / Q000627:therapeutic use*; D016781:Toxoplasmosis, Cerebral / Q000150:complications / Q000188:drug therapy*
D000981:Antiprotozoal Agents; D009285:Naphthoquinones; D053626:Atovaquone
Efficacité de l'atovaquone dans les toxoplasmoses résistantes du SIDA.